ViiV Healthcare GmbH is a wholly-owned subsidiary of ViiV Healthcare (Overseas) Limited and acts as a distribution company for HIV medications in Germany. The company manages a portfolio of 13 products, including innovative long-acting injections and established HIV therapies such as Dovato and Triumeq. The entity is integrated into the global risk management and control system of the ViiV Healthcare group, which was founded in 2009 by GlaxoSmithKline, Pfizer, and Shionogi. The operational focus lies on ensuring patient care and optimizing market share in a highly competitive environment.
Vertrieb von pharmazeutischen Erzeugnissen in verarbeitetem oder unverarbeitetem Zustand sowie Eintragung, Erwerb und Veräußerung von Patenten auf diesem Gebiet sowie deren Auswertung und Vergabe von Lizenzen an Dritte.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) München Local Court, HRB 150477 (as of 29 August 2026)
Source: German Commercial Register (Handelsregister) München Local Court, HRB 150477 (as of 29 August 2026)
Source: German Commercial Register (Handelsregister) München Local Court, HRB 150477 (as of 29 August 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) München Local Court, HRB 150477 (as of 29 August 2026)
Sign in to view detailed salary and cost trends.
